hotspot -WSS

hotspot

author：knowledge 2025-09-30 08:50:01 - browse：77

Illustration of a road with a chasm in the middle, indicating the end of a deal or a problem with a deal — Adobe

A deal is never really done until it’s done.

On Tuesday, two different proposed insurance plan acquisitions on different sides of the country called it quits — one of them for the second time.

California-based Medicare Advantage insurer SCAN Group has been trying to buy CareOregon, an insurer offering coverage to half a million people in Oregon’s state health plan, since January 2023. National insurer Elevance has also been trying to buy Blue Cross and Blue Shield of Louisiana since last January. The on-again, off-again purchase was paused in September 2023 because of state regulators’ concerns, but was resubmitted with a slightly different plan in December.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Guidelines to prevent youth baseball injuries need more muscle
Next article： Change Healthcare can notify patients about the breach, HHS says

knowledge

WSS

Letters to First Opinion on caregivers, digital health, and more

Shifting the focus from loneliness to social health

FDA's Pazdur wants cancer trials to range beyond China alone

A new drug could help frostbite victims avoid its ravages

Woman returns to dialysis after doctors remove transplanted pig kidney

Medicare Advantage enrollment hits roughly 33.4 million

leisure time

hotspot

knowledge

Heart attack and stroke risk calculators need revising

Ukraine seeks to reclaim its role as a hub for clinical trials

How one medical school became remarkably diverse

Elevance, SCAN deals highlight health insurer acquisition scrutiny

At least 13 dead in Texas as scorching temps continue

A new drug could help frostbite victims avoid its ravages

George Santos makes 1st court appearance after pleading not guilty to 13 counts

Ukraine seeks to reclaim its role as a hub for clinical trials

How one medical school became remarkably diverse

ASCO: AstraZeneca's hat trick, and palliative care's spotlight

hotspot

For one rare type of lung cancer, Pfizer pill reduces progression by 81%

Ring Therapeutics, a Flagship gene therapy startup, lays off 20% of staff

Readout Newsletter: Bayer, Rapt Therapeutics, Sanofi shortage

Measles policy set amid Florida outbreak alarms vaccine proponents

ASCO 2024: 'Reassuring' Corbus data on ADC bladder cancer drug

The Pandemic Treaty must support building strong health systems

focus

explore

knowledge

hotspot